Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study

NCT05056194 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Parkinson Disease
Excessive Daytime Somnolence

Interventions

DRUG: Valiloxybate
OTHER: Placebo

Sponsor

XWPharma